Treatment and prevention of acute hepatic encephalopathy by intravenous levodopa.
D000328:Adult; D000368:Aged; D001803:Blood Transfusion; D001921:Brain / Q000503:physiopathology; D006502:Budd-Chiari Syndrome / Q000150:complications; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000150:complications / Q000209:etiology / Q000628:therapy; D006501:Hepatic Encephalopathy / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008107:Liver Diseases / Q000097:blood / Q000150:complications* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use; D014682:Vena Cava, Inferior / Q000002:abnormalities
D004295:Dihydroxyphenylalanine; D009355:Neomycin